These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8699058)

  • 1. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin.
    Brew BJ; Dunbar N; Pemberton L; Kaldor J
    J Infect Dis; 1996 Aug; 174(2):294-8. PubMed ID: 8699058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection.
    Bogner JR; Junge-Hülsing B; Kronawitter U; Sadri I; Matuschke A; Goebel FD
    Clin Investig; 1992 Aug; 70(8):665-9. PubMed ID: 1392442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
    Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
    AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid neopterin and beta 2-microglobulin levels in neurologically asymptomatic HIV-infected patients before and after initiation of zidovudine treatment.
    Hagberg L; Norkrans G; Andersson M; Wachter H; Fuchs D
    Infection; 1992; 20(6):313-5. PubMed ID: 1293049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.
    Gisslén M; Chiodi F; Fuchs D; Norkrans G; Svennerholm B; Wachter H; Hagberg L
    Scand J Infect Dis; 1994; 26(5):523-33. PubMed ID: 7855550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status.
    Lucey DR; McGuire SA; Abbadessa S; Hall K; Woolford B; Valtier S; Butzin CA; Melcher GP; Hendrix CW
    Viral Immunol; 1993; 6(4):267-72. PubMed ID: 7909441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
    McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
    Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex.
    Brew BJ; Dunbar N; Druett JA; Freund J; Ward P
    AIDS; 1996 Oct; 10(12):1357-60. PubMed ID: 8902064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiretroviral therapy on the cerebrospinal fluid of patients seropositive for the human immunodeficiency virus.
    Gulevich SJ; McCutchan JA; Thal LJ; Kirson D; Durand D; Wallace M; Mehta P; Heyes MP; Grant I
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):1002-7. PubMed ID: 8101873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
    Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
    J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
    Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
    Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
    Shi M; Taylor JM; Fahey JL; Hoover DR; Muñoz A; Kingsley LA
    J Clin Immunol; 1997 Jan; 17(1):43-52. PubMed ID: 9049785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated neopterin and beta 2-microglobulin levels in blood and cerebrospinal fluid occur early in HIV-1 infection.
    Sönnerborg AB; von Stedingk LV; Hansson LO; Strannegård OO
    AIDS; 1989 May; 3(5):277-83. PubMed ID: 2504231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of several markers in the progression to acquired immunodeficiency syndrome.
    Planella T; Cortés M; Martínez-Brú C; Barrio J; Sambeat MA; González-Sastre F
    Clin Chem Lab Med; 1998 Mar; 36(3):169-73. PubMed ID: 9589805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence of the hazard of AIDS on markers.
    Yong FH; Taylor JM; Bryant JL; Chmiel JS; Gange SJ; Hoover D
    AIDS; 1997 Feb; 11(2):217-28. PubMed ID: 9030370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease.
    Hagberg L; Andersson M; Chiodi F; Fuchs D; Svennerholm B; Wachter H; Norkrans G
    Scand J Infect Dis; 1991; 23(6):681-5. PubMed ID: 1815328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals.
    Bass HZ; Hardy WD; Mitsuyasu RT; Taylor JM; Wang YX; Fischl MA; Spector SA; Richman DD; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1992; 5(3):215-21. PubMed ID: 1346807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.